CNS cancer: Breaking boundaries - IDH mutations in glioma.

doi:10.1038/nrclinonc.2016.3

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

CNS cancer: Breaking boundaries - IDH mutations in glioma.

Nature reviews. Clinical oncology - 1 Feb 2016

Killock David

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Expression Regulation, Neoplastic
Share to Glioma
Share to Isocitrate Dehydrogenase
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oncogenes

Source

Open in PubMed

Identifiers

PMID: 26787277
DOI: 10.1038/nrclinonc.2016.3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CNS cancer: Breaking boundaries - IDH mutations in glioma.PMID 26787277Read ↗

Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.Semantic proximity Read ↗

A new era for glioma therapy - targeting mutant IDH.Semantic proximity Read ↗

Updates on the WHO diagnosis of IDH-mutant glioma.Semantic proximity Read ↗

Understanding the Genetic Risk of IDH-Mutant Glioma.Semantic proximity Read ↗

Glioma IDH1 mutation patterns off the beaten track.Semantic proximity Read ↗

IDH inhibition in gliomas: from preclinical models to clinical trialsSemantic proximity Read ↗

[IDH mutation on glioma].Semantic proximity Read ↗

Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencingSemantic proximity Read ↗

IDH mutation testing in gliomas-where do we draw the line?Semantic proximity Read ↗

A comprehensive overview on the molecular biology of human glioma: what the clinician needs to knowSemantic proximity Read ↗

Glioblastoma: histone mutations take the MYCN.Semantic proximity Read ↗

CNS cancer: molecular classification of glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.